The Journal of Immunology, Vol 138, Issue 12 4150-4158, Copyright © 1987 by American Association of Immunologists

ARTICLES

Monoclonal anti-Id antibodies react with varying proportions of human B lineage cells

M Kiyotaki, MD Cooper, LF Bertoli, JF Kearney and H Kubagawa

Monoclonal antibodies to idiotypic determinants are being used with increasing frequency for analysis and treatment of B cell malignancies. In the present study we have compared the idiotypic specificities of a panel of 39 mouse monoclonal anti-idiotype (anti-Id) antibodies developed against 16 monoclonal human immunoglobulins (Ig). The Id cross-reactivities of these antibodies with Ig products of normal and abnormal B cells were examined by immunofluorescence and immunochemical methods. The reactivity patterns of these anti-Id antibodies with a normal population of plasma cells were highly variable in the immunofluorescence assay. Six were reactive with 2 to 10% of normal plasma cells, 30 with 0.1 to 2% of plasma cells, and three with less than 0.1% of plasma cells from blood, bone marrow, spleen, or tonsils. These reactivity patterns were relatively consistent among samples from 23 Caucasian, black, and Oriental adults. Although the reactivities of most anti-Id antibodies in the panel were not restricted to a particular Ig isotype, several were preferentially reactive with a particular heavy or light chain isotype: one IgM-, two IgA-, two kappa- , and three lambda-restricted antibodies. The immunofluorescence data was confirmed by biosynthetic analysis of Id+ molecules produced by a normal plasma cell population. When the reactivity of this panel of anti-Id antibodies with nonhomologous B cell neoplasms was examined, seven of 30 myelomas or leukemia-derived products and one of nine B cell leukemias or lymphomas without paraproteins were found to be cross- reactive with one or two of the anti-Id antibodies. Although clearly significant, the cross-reactivity between the Id of these paraproteins appeared to be of lower affinity than the reactivity of the homologous Id with their respective anti-Id antibodies. The results reveal a remarkable diversity in the specificities of monoclonal antibodies classified by conventional criteria as anti-Id antibodies, and indicate the potential usefulness of a panel of antibodies for analyzing clonal diversity in normal and abnormal B cell development.

This article has been cited by other articles:

				I. Torii, S. Oka, M. Hotomi, W. H. Benjamin Jr, T. Takai, J. F. Kearney, D. E. Briles, and H. Kubagawa PIR-B-Deficient Mice Are Susceptible to Salmonella Infection J. Immunol., September 15, 2008; 181(6): 4229 - 4239. [Abstract] [Full Text] [PDF]

				T. Matysiak-Budnik, I. C. Moura, M. Arcos-Fajardo, C. Lebreton, S. Menard, C. Candalh, K. Ben-Khalifa, C. Dugave, H. Tamouza, G. van Niel, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease J. Exp. Med., January 21, 2008; 205(1): 143 - 154. [Abstract] [Full Text] [PDF]

				I. C. Moura, M. Arcos-Fajardo, C. Sadaka, V. Leroy, M. Benhamou, J. Novak, F. Vrtovsnik, E. Haddad, K. R. Chintalacharuvu, and R. C. Monteiro Glycosylation and Size of IgA1 Are Essential for Interaction with Mesangial Transferrin Receptor in IgA Nephropathy J. Am. Soc. Nephrol., March 1, 2004; 15(3): 622 - 634. [Abstract] [Full Text] [PDF]

				K. Benlagha, P. Guglielmi, M. D. Cooper, and K. Lassoued Modifications of Igalpha and Igbeta Expression as a Function of B Lineage Differentiation J. Biol. Chem., July 2, 1999; 274(27): 19389 - 19396. [Abstract] [Full Text] [PDF]

				H. Kubagawa, C.-C. Chen, Le Hong Ho, T. Shimada, L. Gartland, C. Mashburn, T. Uehara, J. V. Ravetch, and M. D. Cooper Biochemical Nature and Cellular Distribution of the Paired Immunoglobulin-like Receptors, PIR-A and PIR-B J. Exp. Med., January 18, 1999; 189(2): 309 - 318. [Abstract] [Full Text] [PDF]